Particle Therapy Market Report 2026

Particle Therapy Market Overview

• Particle Therapy market size has reached to $1.36 billion in 2025 • Expected to grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: Rising Cancer Prevalence Fueling Growth In The Particle Therapy Market • Market Trend: Innovative Therapies Transforming The Particle Therapy Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Particle Therapy Market?

Particle therapy is a specialized cancer treatment that utilizes charged particles, such as protons or heavier ions, to deliver radiation therapy to cancerous tumors. Particle therapy mainly treats cancer by aiming for energetic ionizing particles at the tumor site. Its goal is to enhance treatment results for patients with different types of tumors, especially those that are challenging to address with standard radiation therapy. The main types of therapies in particle therapy are proton therapy and heavy ion therapy. Proton therapy refers to a specialized form of radiation therapy used in the treatment of cancer. It includes single-room systems and multi-room systems. It is used to treat various cancers, such as pediatric cancer, prostate cancer, lung cancer, breast cancer, brain and spinal cord cancer, and others. The main end users are hospitals and academic and research centers.

What Is The Particle Therapy Market Growth Forecast?

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to expansion of personalized cancer treatment approaches, increasing healthcare spending on advanced oncology care, growing demand for precision radiation therapies, technological advancements in accelerator systems, rising adoption in emerging healthcare markets. Major trends in the forecast period include increasing adoption of pencil beam scanning systems, rising deployment of single-room particle therapy centers, growing use of carbon ion therapy, expansion of precision treatment planning capabilities, enhanced focus on pediatric oncology applications.

Global Particle Therapy Market Segmentation

1) By Type: Proton Therapy, Heavy Ion Therapy 2) By System: Single-Room Systems, Multi-Room Systems 3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types 4) By End-User: Hospital, Academic And Research Centers Subsegments: 1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT) 2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy

What Is The Driver Of The Particle Therapy Market?

The growing prevalence of cancer is expected to propel the growth of the particle therapy market going forward. Cancer refers to a complex and diverse group of diseases characterized by the abnormal growth and proliferation of cells in the body. Particle therapy primarily treats cancer with precise and effective radiation, where positively charged particles (protons) are accelerated to high speeds and then focused on the tumor. For instance, in April 2024, according to the International Agency for Research on Cancer (IARC), a France-based, intergovernmental agency, in 2022, nearly 20 million new cancer cases were reported, resulting in almost 10 million deaths due to the disease. Predictions based on demographic trends suggest that the annual incidence of new cancer cases could rise to 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the growing prevalence of cancer is driving the growth of the particle therapy industry.

Key Players In The Global Particle Therapy Market

Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

Global Particle Therapy Market Trends and Insights

Major companies operating in the particle therapy market are increasing their focus on developing innovative therapies, such as the proton therapy solution, to gain a competitive edge in the market. Proton therapy technology is a form of advanced cancer treatment that utilizes protons and positively charged particles to deliver precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, received clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution for sales in the USA. The solution is an affordable proton therapy technology for targeted treatment of cancer with significantly reduced treatment-related side effects. The P-Cure innovative upright solution is the world's first FDA-approved methodology for patient positioning, allowing patients to be treated seated, enhancing patient comfort and clinical results.

What Are Latest Mergers And Acquisitions In The Particle Therapy Market?

In February 2025, Ion Beam Applications S.A. (IBA), a Belgium-based provider of particle accelerator technology and proton therapy solutions, partnered with the Asian Institute of Gastroenterology (AIG) to enhance cancer care in South Asia with advanced proton therapy. Under this partnership, IBA will supply its ProteusONE compact proton therapy system to the new Oncology Centre at AIG Hospitals’ Gachibowli campus in Hyderabad, India, supporting the expansion of cutting-edge proton therapy capabilities in the region. AIG Hospitals is an India-based healthcare institution specializing in gastroenterology and comprehensive cancer care services.

Regional Outlook

North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Particle Therapy Market?

The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.